In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
PREGNANCY: Insufficient data in pregnant women available to inform drug-related risks with use in pregnancy.
Berotralstat should not be used for treatment of acute attacks of hereditary angioedema. Additional doses or doses of berotralstat higher than 150 mg once daily are not recommended. An increase in QT was observed at dosages higher than the recommended 150 mg once daily dosage and was concentration dependent.
Please login to view the rest of this drug profile.